BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27696542)

  • 1. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 2. NRAS
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
    Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
    Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
    Mitre V; Heym K; Clark GD; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocutaneous melanosis with leptomeningeal melanoma.
    Akinwunmi J; Sgouros S; Moss C; Grundy R; Green S
    Pediatr Neurosurg; 2001 Nov; 35(5):277-9. PubMed ID: 11741125
    [No Abstract]   [Full Text] [Related]  

  • 6. Large primary meningeal melanoma in an adult patient with neurocutaneous melanosis.
    Kiecker F; Hofmann MA; Audring H; Brenner A; Labitzke C; Sterry W; Trefzer U
    Clin Neurol Neurosurg; 2007 Jun; 109(5):448-51. PubMed ID: 17382464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare presentation in an adult patient with neurocutaneous melanosis.
    Ge P; Wang H; Zhong Y; Chen B; Ling F; Luo Y
    Int J Dermatol; 2010 Nov; 49(11):1311-3. PubMed ID: 20964655
    [No Abstract]   [Full Text] [Related]  

  • 8. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
    Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
    Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocutaneous melanomatosis with a rapidly deteriorating course.
    Chu WC; Lee V; Chan YL; Shing MM; Chik KW; Li CK; Ma KC
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):287-90. PubMed ID: 12591651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mystery Case: Neurocutaneous melanosis with diffuse leptomeningeal malignant melanoma in an adult.
    Bhatia R; Kataria V; Vibha D; Kakkar A; Prasad K; Mathur S; Garg A; Bakhshi S
    Neurology; 2016 Feb; 86(8):e75-9. PubMed ID: 26903493
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
    Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
    J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.
    van Engen-van Grunsven AC; Rabold K; Küsters-Vandevelde HV; Rijntjes J; Djafarihamedani M; Hehir-Kwa JY; Küsters B; Willemsen MA; van der Burgt I; Wesseling P; Blokx WA; Groenen PJ
    Acta Neuropathol; 2017 Feb; 133(2):333-335. PubMed ID: 27988846
    [No Abstract]   [Full Text] [Related]  

  • 13. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
    Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
    Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma.
    Kinsler VA; Polubothu S; Calonje JE; Chong WK; Thompson D; Jacques TS; Morrogh D
    Acta Neuropathol; 2017 Feb; 133(2):329-331. PubMed ID: 27933403
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
    Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
    Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
    Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
    BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal leptomeningeal melanoma in neurocutaneous melanosis.
    Furtado S; Furtado SV; Ghosal N; Hegde AS
    Pediatr Dermatol; 2012; 29(3):358-61. PubMed ID: 21906139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
    Gerami P; Paller AS
    J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric systemic lupus erythematosus in a girl with neurocutaneous melanosis caused by a somatic mutation in NRAS.
    Inoguchi T; Takenouchi T; Yamazaki F; Kondo Y; Mitamura H; Kosaki K; Takahashi T
    Rheumatology (Oxford); 2022 Aug; 61(8):e224-e226. PubMed ID: 35238342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neurocutaneous melanosis and malignant melanoma].
    Tartler U; Mang R; Schulte KW; Hengge U; Megahed M; Reifenberger J
    Hautarzt; 2004 Oct; 55(10):971-4. PubMed ID: 15365641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.